Measuring quality and outcomes in urological patients
Official title: Quality and Outcome Measurements of Urological Patients
Run by Insel Gruppe AG, University Hospital Bern · NCT04763538 · Data updated 2026-11-12
This study is trying to gather information from patients with urological conditions to see how well different treatments are working and improve care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | Insel Gruppe AG, University Hospital Bern Academic / other |
| Locations | 2 sites (Biel and 1 other locations) |
| Status | Recruiting |
| Started | September 1, 2021 |
| Main results expected | April 30, 2026 |
| Study ends | April 30, 2028 |
| Registry record updated | March 10, 2023 |
| Trial ID | NCT04763538 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include all patients receiving treatment for urological diseases at the participating sites who provide informed consent.
✕Probably not a fit
Patients who do not consent to the recording of their medical history will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to collect and analyze various parameters from urological patients treated at specific sites. Data will be stored in multilayered databases, and once a sufficient sample size is reached, neural networks will be utilized to identify clinical endpoints. The study will include patients with uro-oncological conditions as well as other urological diseases, focusing on standard care practices.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of treatment outcomes in urological diseases, leading to improved patient care.
How similar studies have gone: While similar observational studies have been conducted, the use of neural networks for defining clinical endpoints in this specific context is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients treated at the study sites, signed informed consent Exclusion Criteria: * No consent to record medical history
Where it's running
-
Department of Urology, Hospital Center Biel
Biel, Switzerland Recruiting -
Roland Seiler
Biel, Switzerland Not yet recruiting
Study contacts
- Study coordinator: Roland Seiler, Prof.
- Email: Roland.Seiler@insel.ch
- Phone: +41316321349
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Urine, perineal, and stool microbiota in children and adolescents
We will test whether the bacteria in voided urine, around the genitals, and in stool differ between children with overactive bladder or daytime wetting and healthy children of the same age and gender.
-
21-day comprehensive spa care for kidney and urinary conditions
This program will try a 21-day spa treatment with mineral water baths, drinking cures, exercise and diet for adults 40–70 who have chronic kidney or urinary problems to see if it improves symptoms and kidney health.
-
Hospital admissions for blood in the urine
This international observational project will look at how hospitals manage adults admitted with blood in the urine to see which approaches lead to shorter stays and better outcomes.
-
Using AI language models to help diagnose and recommend treatments for urologic conditions
This project will test whether three AI language models (ChatGPT, Gemini, DeepSeek) can accurately recognize urologic diseases and suggest diagnoses and treatments from archived hospital records of adult patients.
-
Virtual reality to reduce pain and anxiety during outpatient urology procedures
This trial will try a virtual reality headset (REALICA®) to reduce pain and anxiety for adults having outpatient urology procedures such as circumcision, prostate biopsy, or flexible cystoscopy.
-
Using vorolanib for treating advanced kidney cancer
This study is testing if the drug vorolanib can help people with advanced kidney cancer live longer when used as a second treatment option.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.